tradingkey.logo


tradingkey.logo


Heartflow Inc

HTFL
24.690USD
-1.190-4.60%
終倀 03/27, 16:00ET15分遅れの株䟡
1.99B時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Heartflow Inc 䌁業名

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Heartflow Incの䌁業情報


䌁業コヌドHTFL
䌚瀟名Heartflow Inc
䞊堎日Aug 08, 2025
最高経営責任者「CEO」Farquhar (John C. M)
埓業員数699
蚌刞皮類Ordinary Share
決算期末Aug 08
本瀟所圚地331 E Evelyn Avenue
郜垂MOUNTAIN VIEW
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号94041
電話番号16502411221
りェブサむトhttps://www.heartflow.com/
䌁業コヌドHTFL
䞊堎日Aug 08, 2025
最高経営責任者「CEO」Farquhar (John C. M)

Heartflow Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
191.81K
+35.43%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
--
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
--
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
--
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John C. M. Farquhar
Mr. John C. M. Farquhar
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Julie Cullivan
Ms. Julie Cullivan
Independent Director
Independent Director
--
--
Mr. Tim Barabe
Mr. Tim Barabe
Independent Director
Independent Director
--
--
Dr. Wayne Riley, M.D.
Dr. Wayne Riley, M.D.
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
191.81K
+35.43%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
--
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
--
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
--
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
United states
42.95M
92.80%
United kingdom
1.52M
3.28%
Japan
1.46M
3.16%
Rest of europe
349.00K
0.75%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, Feb 19
曎新時刻: Thu, Feb 19
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Wellington Management Company, LLP
13.90%
Bain Capital Life Sciences Investors, LLC
12.18%
HealthCor Partners Management LP
7.81%
Fidelity Management & Research Company LLC
4.69%
Hayfin Capital Management LLP
4.24%
他の
57.18%
株䞻統蚈
株䞻統蚈
比率
Wellington Management Company, LLP
13.90%
Bain Capital Life Sciences Investors, LLC
12.18%
HealthCor Partners Management LP
7.81%
Fidelity Management & Research Company LLC
4.69%
Hayfin Capital Management LLP
4.24%
他の
57.18%
皮類
株䞻統蚈
比率
Investment Advisor
48.61%
Investment Advisor/Hedge Fund
23.88%
Hedge Fund
4.68%
Individual Investor
2.77%
Bank and Trust
0.41%
Endowment Fund
0.36%
Research Firm
0.30%
Venture Capital
0.18%
Sovereign Wealth Fund
0.04%
他の
18.77%

機関投資家保有株


曎新時刻: Wed, Jan 21
曎新時刻: Wed, Jan 21
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q4
129
59.51M
43.48%
--
2025Q4
157
60.44M
71.29%
+22.15M
2025Q3
46
45.42M
54.46%
+42.91M

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Wellington Management Company, LLP
4.88M
5.73%
+465.57K
+10.55%
Sep 30, 2025
Bain Capital Life Sciences Investors, LLC
12.45M
14.62%
--
--
Sep 30, 2025
HealthCor Partners Management LP
6.70M
7.86%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
4.62M
5.42%
+1.33M
+40.42%
Sep 30, 2025
Hayfin Capital Management LLP
3.64M
4.27%
-1.00
-0.00%
Sep 30, 2025
Baillie Gifford & Co.
3.01M
3.53%
+415.89K
+16.06%
Sep 30, 2025
Baron Capital Management, Inc.
1.24M
1.45%
+1.24M
--
Sep 30, 2025
Schusterman Interests LLC
1.94M
2.28%
+1.94M
--
Sep 30, 2025
Capricorn Investment Group LLC
3.92M
4.61%
+3.92M
--
Aug 08, 2025
The Vanguard Group, Inc.
1.45M
1.7%
+285.27K
+24.45%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
TrueShares Technology, AI & Deep Learning ETF
3.13%
Global X HealthTech ETF
1.75%
Fidelity Blue Chip Growth ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.06%
iShares Health Innovation Active ETF
0.02%
Schwab U.S. Small-Cap ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Schwab U.S. Broad Market ETF
0%
TrueShares Technology, AI & Deep Learning ETF
比率3.13%
Global X HealthTech ETF
比率1.75%
Fidelity Blue Chip Growth ETF
比率0.07%
T Rowe Price Small-Mid Cap ETF
比率0.06%
iShares Health Innovation Active ETF
比率0.02%
Schwab U.S. Small-Cap ETF
比率0.02%
Fidelity Nasdaq Composite Index ETF
比率0.01%
Schwab U.S. Broad Market ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™